Logo

Dana-Farber

In Brief This Week: Quest Diagnostics, Biodexis, Caris Life Sciences, SkylineDx, and More

News items for the in vitro diagnostics industry for the week of Feb. 15, 2021.

Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy

Investigators reported on how ctDNA, measured using Natera's patient-specific Signatera assays, corresponded to a patient's disease progression and other biomarkers.

Grail Multi-Cancer Test Meets Validation Goals; Patients to Receive Results Under New Pilot

Researchers published the most comprehensive data to date showing that Grail's screening approach can detect and distinguish a significant number of cancers.

Dana Faber Cancer Institute, AroCell Evaluating Use of ELISA to Detect Cancer Marker

They are seeking to determine the concordance between thymidine kinase 1 enzyme concentration in serum and patients' clinical response to treatment.

Gray Foundation Awards $25M in Cancer Research Grants

The grant recipients will receive up to $5 million each and are led by scientists at institutions including Harvard Medical School and the Cleveland Clinic.